The synanamorphs and teleomorphs of Phoma have been poorly investigated thus far, except for the P. lingam complex. Few synanamorph relationships have thus far been confirmed by means of molecular techniques. Arenal et al. (2000, 2004) demonstrated P. epicoccina and Epicoccum nigrum to be synanamorphs by employing ITS sequence data, and synonymised these species after further microscopical studies."

"Additionally, deep-seated infections generally exhibit a predilection for immunocompromised hosts, but cases with cerebral dissemination are more common in immunocompetent individuals. "

Coelomycetous fungi in human disease. A review: Clinical entities, pathogenesis, identification and therapy

Deanna A. Sutton

Coelomycetous Fungi in the Clinical Setting: Morphological Convergence and Cryptic Diversity

Nicomedes Valenzuela-Lopez, Deanna A. Sutton, José F. Cano-Lira, Katihuska Paredes,

Nathan Wiederhold, Josep Guarro, and Alberto M. Stchigel

David W. Warnock, Editor

David W. Warnock, University of Manchester;

, ,

Rungtiwa Phookamsak, Jian-Kui Liu, Eric H. C. McKenzie, Dimuthu S. Manamgoda, Hiran Ariyawansa, Kasun M. Thambugala, Dong-Qin Dai, Erio Camporesi, Ekachai Chukeatirote, Nalin N. Wijayawardene, Ali H. Bahkali, Peter E. Mortimer, Jian-Chu Xu & Kevin D. Hyde

Antimicrobial blue light inactivation of international clones of multidrug-resistant Escherichia coli ST10, ST131 and ST648

International clones of multidrug-resistant Escherichia coli have been a leading cause of human and animal infections worldwide. Microbial inactivation by blue light has been proposed as an effective treatment for superficial infections and surface contamination.

Carolina dos Anjos, Caetano P. Sabino, Vanessa Bueris, Miriam R. Fernandes, Fabio C.Pogliani, Nilton Lincopan,

Fábio P. Sellera

Antimicrobial Blue Light And Quinine Combo Effective For Treatment Of Mold Infection: Study

New Insights into the Bacterial Targets of Antimicrobial Blue Light

Escherichia coli ST131, an Intriguing Clonal Group

In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131), was identified on three continents. Today, ST131 is the predominant E. coli lineage among extra-intestinal pathogenic E. coli (ExPEC) isolates worldwide.

Retrospective studies have suggested that it may originally have risen to prominence as early as 2003

Marie-Hélène Nicolas-Chanoine, Xavier Bertrand, and Jean-Yves Madec

Global dissemination of a multidrug-resistant Escherichia coli clone

Nicola K. Pettya,b,c,1, Nouri L. Ben Zakoura,b,1, Mitchell Stanton-Cooka,b, Elizabeth Skippingtona,b, Makrina Totsikaa,b,Brian M. Fordea,b, Minh-Duy Phana,b, Danilo Gomes Moriela,b, Kate M. Petersa,b, Mark Daviesa,b,d, Benjamin A. Rogerse,Gordon Dougand, Jesús Rodriguez-Bañof,g, Alvaro Pascualf,g, Johann D. D. Pitouth,i, Mathew Uptonj,David L. Patersona,e, Timothy R. Walshk, Mark A. Schembria,b,2, and Scott A. Beatsona,b,